FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155122198> ?p ?o ?g. }

• W2155122198 endingPage "1034" @default.
• W2155122198 startingPage "1029" @default.
• W2155122198 abstract "ABSTRACT The use of human immunodeficiency virus (HIV) protease inhibitors in children has lagged behind that in adults because of the lack of suitable pediatric formulations and information on safe and effective dosing regimens. This study was designed to obtain pharmacokinetic information on indinavir, administered to HIV-infected children also receiving therapy with two nucleoside agents, and to explore relationships between pharmacokinetic parameters and anti-HIV effect. Indinavir was initiated at a dose of 500 mg/m 2 every 8 h. Plasma indinavir concentrations were measured every 4 weeks; the dose or dosing interval was adjusted to maintain trough concentrations of ≥0.1 mg/liter. All children were evaluated clinically at baseline and every 4 weeks. Plasma HIV RNA was quantitated at baseline and at weeks 4, 12, and 24. Eighteen children participated in this study. The average daily dose of indinavir was 2,043 mg/m 2 ; nine children received indinavir at 6-h intervals. Pharmacokinetic characteristics of indinavir (mean ± standard deviation) were the following: oral clearance, 1.4 ± 0.5 liters/h/kg; half-life, 1.1 ± 0.43 h; and trough concentration, 0.29 ± 0.32 mg/liter. In nine children that completed 24 weeks of therapy, the baseline-to-week-24 change in HIV RNA level was related to indinavir trough concentration and didanosine area under the curve. This study illustrates the ability to obtain pharmacokinetic information from children during routine clinic visits and to use this information to provide a safeguard against underdosing. The incorporation of pharmacologic knowledge with virologic, immunologic, and behavioral considerations should result in improved clinical outcomes for children infected with HIV." @default.
• W2155122198 created "2016-06-24" @default.
• W2155122198 creator A5002009823 @default.
• W2155122198 creator A5004183415 @default.
• W2155122198 creator A5014042916 @default.
• W2155122198 creator A5015807341 @default.
• W2155122198 creator A5017051528 @default.
• W2155122198 creator A5028352176 @default.
• W2155122198 creator A5060312532 @default.
• W2155122198 creator A5062913699 @default.
• W2155122198 date "2000-04-01" @default.
• W2155122198 modified "2023-10-13" @default.
• W2155122198 title "Pharmacologic Characteristics of Indinavir, Didanosine, and Stavudine in Human Immunodeficiency Virus-Infected Children Receiving Combination Therapy" @default.
• W2155122198 cites W1519158032 @default.
• W2155122198 cites W1524784524 @default.
• W2155122198 cites W1567068711 @default.
• W2155122198 cites W1997151749 @default.
• W2155122198 cites W2012423913 @default.
• W2155122198 cites W2018429770 @default.
• W2155122198 cites W2025937041 @default.
• W2155122198 cites W2028286328 @default.
• W2155122198 cites W2053286376 @default.
• W2155122198 cites W2078326422 @default.
• W2155122198 cites W2327723086 @default.
• W2155122198 doi "https://doi.org/10.1128/aac.44.4.1029-1034.2000" @default.
• W2155122198 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/89808" @default.
• W2155122198 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10722507" @default.
• W2155122198 hasPublicationYear "2000" @default.
• W2155122198 type Work @default.
• W2155122198 sameAs 2155122198 @default.
• W2155122198 citedByCount "67" @default.
• W2155122198 countsByYear W21551221982012 @default.
• W2155122198 countsByYear W21551221982015 @default.
• W2155122198 countsByYear W21551221982016 @default.
• W2155122198 countsByYear W21551221982018 @default.
• W2155122198 countsByYear W21551221982023 @default.
• W2155122198 crossrefType "journal-article" @default.
• W2155122198 hasAuthorship W2155122198A5002009823 @default.
• W2155122198 hasAuthorship W2155122198A5004183415 @default.
• W2155122198 hasAuthorship W2155122198A5014042916 @default.
• W2155122198 hasAuthorship W2155122198A5015807341 @default.
• W2155122198 hasAuthorship W2155122198A5017051528 @default.
• W2155122198 hasAuthorship W2155122198A5028352176 @default.
• W2155122198 hasAuthorship W2155122198A5060312532 @default.
• W2155122198 hasAuthorship W2155122198A5062913699 @default.
• W2155122198 hasBestOaLocation W21551221981 @default.
• W2155122198 hasConcept C112705442 @default.
• W2155122198 hasConcept C126322002 @default.
• W2155122198 hasConcept C142462285 @default.
• W2155122198 hasConcept C159047783 @default.
• W2155122198 hasConcept C176674119 @default.
• W2155122198 hasConcept C2776452011 @default.
• W2155122198 hasConcept C2777210460 @default.
• W2155122198 hasConcept C2777288759 @default.
• W2155122198 hasConcept C2777447569 @default.
• W2155122198 hasConcept C2779889181 @default.
• W2155122198 hasConcept C2780727368 @default.
• W2155122198 hasConcept C2993143319 @default.
• W2155122198 hasConcept C3013748606 @default.
• W2155122198 hasConcept C71924100 @default.
• W2155122198 hasConcept C90924648 @default.
• W2155122198 hasConcept C98274493 @default.
• W2155122198 hasConceptScore W2155122198C112705442 @default.
• W2155122198 hasConceptScore W2155122198C126322002 @default.
• W2155122198 hasConceptScore W2155122198C142462285 @default.
• W2155122198 hasConceptScore W2155122198C159047783 @default.
• W2155122198 hasConceptScore W2155122198C176674119 @default.
• W2155122198 hasConceptScore W2155122198C2776452011 @default.
• W2155122198 hasConceptScore W2155122198C2777210460 @default.
• W2155122198 hasConceptScore W2155122198C2777288759 @default.
• W2155122198 hasConceptScore W2155122198C2777447569 @default.
• W2155122198 hasConceptScore W2155122198C2779889181 @default.
• W2155122198 hasConceptScore W2155122198C2780727368 @default.
• W2155122198 hasConceptScore W2155122198C2993143319 @default.
• W2155122198 hasConceptScore W2155122198C3013748606 @default.
• W2155122198 hasConceptScore W2155122198C71924100 @default.
• W2155122198 hasConceptScore W2155122198C90924648 @default.
• W2155122198 hasConceptScore W2155122198C98274493 @default.
• W2155122198 hasIssue "4" @default.
• W2155122198 hasLocation W21551221981 @default.
• W2155122198 hasLocation W21551221982 @default.
• W2155122198 hasLocation W21551221983 @default.
• W2155122198 hasOpenAccess W2155122198 @default.
• W2155122198 hasPrimaryLocation W21551221981 @default.
• W2155122198 hasRelatedWork W1965500718 @default.
• W2155122198 hasRelatedWork W1967589827 @default.
• W2155122198 hasRelatedWork W2025587112 @default.
• W2155122198 hasRelatedWork W2053286376 @default.
• W2155122198 hasRelatedWork W2066184048 @default.
• W2155122198 hasRelatedWork W2069322644 @default.
• W2155122198 hasRelatedWork W2079948480 @default.
• W2155122198 hasRelatedWork W2109213931 @default.
• W2155122198 hasRelatedWork W2125787947 @default.
• W2155122198 hasRelatedWork W2155122198 @default.
• W2155122198 hasVolume "44" @default.
• W2155122198 isParatext "false" @default.
• W2155122198 isRetracted "false" @default.
• W2155122198 magId "2155122198" @default.

• next